Cite
Feasibility of a telehealth-based contingency management intervention for alcohol use disorders using the phosphatidylethanol (PEth) 16:0/18:1 alcohol biomarker: a pilot randomized trial.
MLA
Jett, Julianne D., et al. “Feasibility of a Telehealth-Based Contingency Management Intervention for Alcohol Use Disorders Using the Phosphatidylethanol (PEth) 16:0/18:1 Alcohol Biomarker: A Pilot Randomized Trial.” American Journal of Drug & Alcohol Abuse, vol. 50, no. 2, Mar. 2024, pp. 162–72. EBSCOhost, https://doi.org/10.1080/00952990.2023.2283691.
APA
Jett, J. D., Beck, R., Tyutyunnyk, D., Sanchez, J., Weeks, D. L., Javors, M. A., Hill-Kapturczak, N., Lopez-Cruzan, M., Kriegel, L., Ginsburg, B. C., Cabassa, L., & McDonell, M. G. (2024). Feasibility of a telehealth-based contingency management intervention for alcohol use disorders using the phosphatidylethanol (PEth) 16:0/18:1 alcohol biomarker: a pilot randomized trial. American Journal of Drug & Alcohol Abuse, 50(2), 162–172. https://doi.org/10.1080/00952990.2023.2283691
Chicago
Jett, Julianne D., Rachael Beck, Diana Tyutyunnyk, Jesus Sanchez, Douglas L. Weeks, Martin A. Javors, Nathalie Hill-Kapturczak, et al. 2024. “Feasibility of a Telehealth-Based Contingency Management Intervention for Alcohol Use Disorders Using the Phosphatidylethanol (PEth) 16:0/18:1 Alcohol Biomarker: A Pilot Randomized Trial.” American Journal of Drug & Alcohol Abuse 50 (2): 162–72. doi:10.1080/00952990.2023.2283691.